Shields Capital is a seasoned healthcare investment partnership with a focus on early-stage investments, including Pre-Seed and Series A rounds. The firm typically invests in companies within the healthcare sector, leveraging its extensive experience to support innovative startups. Shields Capital has been providing brokerage services since 1982 and combines the personalized service of an independent firm with the resources of a large institution.
Notable portfolio companies include Lynx, which has raised $15 million, and Thrive Health Tech, with $7 million in funding. Key partners at Shields Capital bring a wealth of experience from their long-standing presence on Wall Street. The firm's investment philosophy centers on using the latest technology and deep industry insights to grow and preserve wealth for their clients. Shields Capital also offers unique value-add services, such as personalized wealth management and enduring client relationships, to support the growth of their portfolio companies.